Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
1
|
pubmed:dateCreated |
1967-4-13
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Jan
|
pubmed:issn |
0022-2623
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
9
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
142-3
|
pubmed:dateRevised |
2008-11-21
|
pubmed:meshHeading |
pubmed-meshheading:5335136-Bridged Compounds,
pubmed-meshheading:5335136-Chemistry, Organic,
pubmed-meshheading:5335136-Escherichia coli,
pubmed-meshheading:5335136-Hydantoins,
pubmed-meshheading:5335136-Inflammation,
pubmed-meshheading:5335136-Nervous System,
pubmed-meshheading:5335136-Organic Chemistry Phenomena
|
pubmed:year |
1966
|
pubmed:articleTitle |
Substitution in the hydantoin ring. 3. Bicyclo(3.3.0)octane derivatives.
|
pubmed:publicationType |
Journal Article
|